These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3258774)
21. [Principles of treatment with cells called "LAK" cells]. Hercend T; Triebel F Bull Cancer; 1988; 75(9):879-84. PubMed ID: 3264731 [TBL] [Abstract][Full Text] [Related]
22. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck. Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620 [TBL] [Abstract][Full Text] [Related]
23. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism. Gamero AM; Ussery D; Reintgen DS; Puleo CA; Djeu JY Cancer Res; 1995 Nov; 55(21):4988-94. PubMed ID: 7585540 [TBL] [Abstract][Full Text] [Related]
24. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy. Mulé JJ; Ettinghausen SE; Spiess PJ; Shu S; Rosenberg SA Cancer Res; 1986 Feb; 46(2):676-83. PubMed ID: 3484431 [TBL] [Abstract][Full Text] [Related]
25. Lymphokine activated killer (LAK) activity in lymphoproliferative disorders. Foa R; Fierro MT; Raspadori D; Bonferroni M; Cardona S; Liao XS; Cesano A; Matera L; Gillio Tos A; Tola E Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():153-5. PubMed ID: 2653494 [TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of alloimmune T cells on the generation of cytolytic responses of lymphokine-activated killer cells. Sugarbaker PH; Matthews W; Steller EP; Eggermont AM J Biol Response Mod; 1987 Aug; 6(4):430-45. PubMed ID: 3498012 [TBL] [Abstract][Full Text] [Related]
27. [LAK cells and cancer]. Taguchi T; Kimoto Y Gan To Kagaku Ryoho; 1986 Dec; 13(12):3327-33. PubMed ID: 3539024 [TBL] [Abstract][Full Text] [Related]
28. Immunotherapy of cancer with lymphokine-activated killer cells and recombinant interleukin-2. Rosenberg SA; Mulé JJ Surgery; 1985 Sep; 98(3):437-44. PubMed ID: 3898451 [TBL] [Abstract][Full Text] [Related]
29. Effect of immunotherapy with allogeneic lymphokine-activated killer cells and recombinant interleukin 2 on established pulmonary and hepatic metastases in mice. Shiloni E; Lafreniere R; Mulé JJ; Schwarz SL; Rosenberg SA Cancer Res; 1986 Nov; 46(11):5633-40. PubMed ID: 3489526 [TBL] [Abstract][Full Text] [Related]
30. Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2. Ettinghausen SE; Rosenberg SA Cancer Res; 1986 Jun; 46(6):2784-92. PubMed ID: 3486038 [TBL] [Abstract][Full Text] [Related]
31. [Observations on the local administration of autologous lymphokine activated killer cells and recombinant interleukin-2 in patients with malignant gliomas]. Yoshida S; Takai N; Ono K; Saito T; Tanaka R No To Shinkei; 1988 Feb; 40(2):119-25. PubMed ID: 3259433 [TBL] [Abstract][Full Text] [Related]
32. [A new approach in the treatment of metastatic melanoma: adoptive immunotherapy using lymphokine-activated killer cells and interleukin 2]. Keilholz U; Welters H; Dummer R; Tilgen W; Hunstein W Hautarzt; 1988 Jun; 39(6):378-81. PubMed ID: 3261288 [TBL] [Abstract][Full Text] [Related]
34. Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma. Lafreniere R; Rosenberg SA J Immunol; 1985 Dec; 135(6):4273-80. PubMed ID: 3877766 [TBL] [Abstract][Full Text] [Related]
35. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943 [TBL] [Abstract][Full Text] [Related]